Sign Up Today and Learn More About Candid Health Stock
Invest in or calculate the value of your shares in Candid Health or other pre-IPO companies through EquityZen's platform.
Candid Health Stock (CANH)
Candid is a modern medical insurance billing platform
About Candid Health Stock
Founded
2019
Headquarters
San Francisco, CA, US
Industries
Software, Artificial Intelligence, Financial Services
Candid Health is a platform that uses AI for automated medical billing. They undergo regular HIPAA audits by industry-leading security experts to protect the client's patients’ security and privacy. And uses AI to learn insurance submission rules in real-time, so they never make the same mistake twice.
Candid Health Press Mentions
Stay in the know about the latest news on Candid Health
2025 MedTech Breakthrough winners for healthcare payments
techtarget • May 17, 2025
Candid Health Wins "Best RCM Solution" Designation in 9th Annual MedTech Breakthrough Awards Program
prnewswire • May 08, 2025
Meet the new tech mafia in town: the Palantir Mafia
businessinsider • May 04, 2025
Candid Health Successfully Completed a Type 1 SOC 2 Examination With an Unqualified Opinion
newswire • Mar 28, 2025
The Weekly Notable Startup Funding Report: 2/17/25
alleywatch • Feb 19, 2025
Candid Health Management
Leadership team at Candid Health
COO
Doug Proctor
Co-founder and CEO
Nick Perry
Join now and verify your accreditation status to gain access to:
- Candid Health Current Valuation
- Candid Health Stock Price
- Candid Health Management
- Available deals in Candid Health and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Candid Health Cap Table and Funding History by Share Class and Liquidity Preferences
- Candid Health Revenue and Financials
- Candid Health Highlights
- Candid Health Business Model
- Candid Health Risk Factors
- Candid Health Research Report from SACRA Research
Trading Candid Health Stock
How to invest in Candid Health stock?
Accredited investors can buy pre-IPO stock in companies like Candid Health through EquityZen funds. These investments are made available by existing Candid Health shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Candid Health stock?
Shareholders can sell their Candid Health stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
